The Vascular and Vein Specialty Market
By 2025, the global varicose vein treatment market projections expects to reach about $589 million in the U.S. This is a compound annual growth rate of 5.7 percent in an eight-year period. The rise in the geriatric population and more obesity in the U.S. creates growing demand for vascular and vein specialty services.
Varicose veins plague more than 40 million women and men in the U.S. Yes, men also get varicose veins. Among those who have varicose veins, half of them have a family history. If one parent has varicose veins, girls have a 60% chance of inheriting them while boys have a 25% chance. Meanwhile, if both parents have varicose veins, the odds are greater that their offspring will have them, too. Close to 90% of children will have varicose veins in their lifetime if both parents have them. Age plays a role, too. Fifty percent of women in the U.S. over 50-years-of age have varicose veins. Moreover, obesity plays a significant role in causation of varicose veins.
As a minimally invasive procedure, varicose vein treatment by vascular physicians may be considered a cosmetic procedure with insurance reimbursement on a case-by-case basis.